{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:15:13Z","timestamp":1793412913391,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ajo.2024.07.035","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T11:07:38Z","timestamp":1723720058000},"page":"30-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Progression Rate of Macular Retinal Pigment Epithelium Atrophy in Geographic Atrophy and Selected Inherited Retinal Dystrophies. A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"269","author":[{"given":"Fabiana L.","family":"Bassil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Colijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberta A.H.J.","family":"Thiadens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2584-4894","authenticated-orcid":false,"given":"Marc","family":"Biarn\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0001","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.molmed.2015.12.007","article-title":"Cell-based therapy for degenerative retinal disease","volume":"22","author":"Zarbin","year":"2016","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ajo.2024.07.035_bib0002","article-title":"Functions and diseases of the retinal pigment epithelium","volume":"12","author":"Yang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajo.2024.07.035_bib0003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.preteyeres.2013.11.001","article-title":"Macular dystrophies mimicking age-related macular degeneration","volume":"39","author":"Saksens","year":"2014","journal-title":"Prog Retin Eye Res"},{"issue":"9827","key":"10.1016\/j.ajo.2024.07.035_bib0004","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.035_bib0005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2013.11.023","article-title":"Geographic atrophy: clinical features and potential therapeutic approaches","volume":"121","author":"Holz","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.07.035_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1009599","article-title":"Exploring the pathogenesis of age-related macular degeneration: a review of the interplay between retinal pigment epithelium dysfunction and the innate immune system","volume":"16","author":"Wong","year":"2022","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bjophthalmol-2016-308823","article-title":"Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options","volume":"101","author":"Tanna","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.035_bib0008","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.exer.2005.01.007","article-title":"RPE lipofuscin and its role in retinal pathobiology","volume":"80","author":"Sparrow","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2024.07.035_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100861","article-title":"Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations","volume":"79","author":"Cremers","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.survophthal.2008.12.006","article-title":"Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches","volume":"54","author":"Finger","year":"2009","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.035_bib0011","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ophtha.2008.12.019","article-title":"Central areolar choroidal dystrophy","volume":"116","author":"Boon","year":"2009","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.035_bib0012","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/bjophthalmol-2019-315086","article-title":"Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options","volume":"104","author":"Rahman","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.035_bib0013","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.07.035_bib0014","article-title":"Iveric Bio receives U.S. FDA Approval for IZERVAY\u2122 (avacincaptad pegol intravitreal solution), a new treatment for geographic atrophy","year":"2023"},{"key":"10.1016\/j.ajo.2024.07.035_bib0015","article-title":"Apellis provides updates on injection kits and rare safety events with SYFOVRE\u00ae (pegcetacoplan injection)","year":"2023"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0016","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/biom11081179","article-title":"Therapy approaches for Stargardt disease","volume":"11","author":"Piotter","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajo.2024.07.035_bib0017","unstructured":"Nct. Stem cell models of best disease and other retinal degenerative diseases. Trial Registry Record. 2014. Accessed September 29, 2023. https:\/\/clinicaltrialsgov\/study\/NCT02162953."},{"issue":"12","key":"10.1016\/j.ajo.2024.07.035_bib0018","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3390\/biomedicines9121895","article-title":"Therapy of pseudoxanthoma elasticum: current knowledge and future perspectives","volume":"9","author":"Stumpf","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajo.2024.07.035_bib0019","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ajo.2024.03.023","article-title":"Association between quantitative and qualitative imaging biomarkers and geographic atrophy growth rate","volume":"264","author":"de Carlo Forest","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/aos.15803","article-title":"Genetic and molecular biomarkers for geographic atrophy","volume":"101","author":"Riley-Gillis","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.035_bib0021","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ophtha.2015.12.009","article-title":"The natural history of the progression of atrophy secondary to Stargardt disease (ProgStar) studies: design and baseline characteristics: progStar report no. 1","volume":"123","author":"Strauss","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.035_bib0022","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.oret.2017.08.018","article-title":"Design characteristics of geographic atrophy treatment trials: systematic review of registered trials in ClinicalTrials.gov","volume":"2","author":"Cheng","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.035_bib0023","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/biomedicines11061548","article-title":"Methodological appraisal of phase 3 clinical trials in geographic atrophy","volume":"11","author":"Biarnes","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.035_bib0024","first-page":"593","article-title":"Geographic atrophy phenotypes in subjects of different ethnicity","volume":"7","author":"Teo","year":"2022","journal-title":"Asia-Pacific Ocular Imaging Society Work Group Report 3"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.035_bib0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/IAE.0000000000003733","article-title":"Fundus autofluorescence in extensive macular atrophy with pseudodrusen and diffuse trickling geographic atrophy","volume":"43","author":"Bianco","year":"2023","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.10.1.3","article-title":"Retinal pigment epithelium atrophy in recessive stargardt disease as measured by short-wavelength and near-infrared autofluorescence","volume":"10","author":"Jauregui","year":"2021","journal-title":"Transl vis sci technol"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2021.100005","article-title":"Atrophy expansion rates in stargardt disease using ultra-widefield fundus autofluorescence","volume":"1","author":"Heath Jeffery","year":"2021","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0028","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000510507","article-title":"Growth rate of geographic atrophy secondary to age-related macular degeneration: a meta-analysis of natural history studies and implications for designing future trials","volume":"64","author":"Wang","year":"2021","journal-title":"Ophthalmic Res"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0029","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/jamaophthalmol.2019.2885","article-title":"Progression of Stargardt disease as determined by fundus autofluorescence over a 12-month period: ProgStar Report No. 11","volume":"137","author":"Strauss","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2024.07.035_bib0030","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.035_bib0031","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2010.08.018","article-title":"Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography","volume":"118","author":"Yehoshua","year":"2011","journal-title":"Ophthalmology"},{"issue":"06","key":"10.1016\/j.ajo.2024.07.035_bib0032","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ajo.2023.02.003","article-title":"Progression of Stargardt disease as determined by fundus autofluorescence over a 24-month period (ProgStar Report No. 17)","volume":"250","author":"Strauss","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.07.035_bib0033","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajo.2024.07.035_bib0034","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (Updated August 2023)","year":"2023"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.035_bib0035","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 Report Number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0036","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","article-title":"Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26","volume":"127","author":"Lindblad","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0037","first-page":"2266","article-title":"One-year results of a phase 2 clinical trial evaluating resveratrol, quercetin, and curcumin (RQC) for the treatment of geographic atrophy","volume":"64","author":"Pfahler","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.035_bib0038","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/13816810.2018.1488174","article-title":"Vitamin A in Stargardt disease-an evidence-based update","volume":"39","author":"Federspiel","year":"2018","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.ajo.2024.07.035_bib0039","series-title":"Version EndNote 21","year":"2013"},{"key":"10.1016\/j.ajo.2024.07.035_bib0040","unstructured":"Wells G.S.B, O'Connell D., Peterson J., Welch V., Losos M., Tuwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. Accessed November 15, 2023. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"7653","key":"10.1016\/j.ajo.2024.07.035_bib0041","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Schunemann","year":"2008","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.ajo.2024.07.035_bib0042","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2024.07.035_bib0043","unstructured":"Stata Statistical Software: release 18. StataCorp LLC; 2023."},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0044","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.ophtha.2014.03.036","article-title":"Vitreoretinal interface changes in geographic atrophy","volume":"121","author":"Abdillahi","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0045","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.oret.2022.03.022","article-title":"Adherence to a Mediterranean diet and geographic atrophy enlargement rate: age-related eye disease Study 2 Report 29","volume":"6","author":"Agron","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0046","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.oret.2022.04.012","article-title":"Differences in long-term progression of atrophy between neovascular and nonneovascular age-related macular degeneration","volume":"6","author":"Airaldi","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.035_bib0047","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.10.6.2","article-title":"Model Structure Uncertainty in the characterization and growth of geographic atrophy","volume":"10","author":"Arslan","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0048","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000361077","article-title":"Geographic atrophy progression in eyes with age-related macular degeneration: role of fundus autofluorescence patterns, fellow eye and baseline atrophy area","volume":"52","author":"Batioglu","year":"2014","journal-title":"Ophthalmic Res"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0049","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00417-018-4167-6","article-title":"Hyperreflective foci in Stargardt disease: 1-year follow-up","volume":"257","author":"Battaglia Parodi","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/IAE.0b013e3181e0958b","article-title":"Use of fundus autofluorescence images to predict geographic atrophy progression","volume":"31","author":"Bearelly","year":"2011","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0051","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/s41433-021-01747-z","article-title":"Fundus autofluorescence and optical coherence tomography biomarkers associated with the progression of geographic atrophy secondary to age-related macular degeneration","volume":"36","author":"Bui","year":"2022","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.12.9.1","article-title":"Impact of prophylactic ranibizumab to prevent neovascular age-related macular degeneration on eyes with intermediate age-related macular degeneration","volume":"12","author":"Chan","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0053","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.exer.2010.03.021","article-title":"Analysis of autofluorescent retinal images and measurement of atrophic lesion growth in Stargardt disease","volume":"91","author":"Chen","year":"2010","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.035_bib0054","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/tvst.9.7.33","article-title":"Factors influencing retinal pigment epithelium-atrophy progression rate in Stargardt disease","volume":"9","author":"Cicinelli","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.oret.2020.07.006","article-title":"Quantification of geographic atrophy using spectral domain OCT in age-related macular degeneration","volume":"5","author":"Cleland","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.035_bib0056","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamaophthalmol.2021.1407","article-title":"Enlargement of geographic atrophy from first diagnosis to end of life","volume":"139","author":"Colijn","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0057","first-page":"3846","article-title":"Progression dynamics of early versus later stage atrophic lesions in nonneovascular age-related macular degeneration using quantitative OCT biomarker segmentation","volume":"51","author":"Coulibaly","year":"2023"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0058","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1167\/iovs.15-18865","article-title":"Relationship between presumptive inner nuclear layer thickness and geographic atrophy progression in age-related macular degeneration","volume":"57","author":"Ebneter","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0059","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1167\/iovs.09-4533","article-title":"Tracking progression with spectral-domain optical coherence tomography in geographic atrophy caused by age-related macular degeneration","volume":"51","author":"Fleckenstein","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.035_bib0060","first-page":"573","article-title":"Randomized phase IIb study of Brimonidine Drug Delivery System Generation 2 for geographic atrophy in age-related macular degeneration","volume":"7","author":"Freeman","year":"2023"},{"issue":"13","key":"10.1016\/j.ajo.2024.07.035_bib0061","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1167\/iovs.13-12104","article-title":"A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations","volume":"54","author":"Fujinami","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2024.07.035_bib0062","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/iovs.63.11.4","article-title":"The fovea-protective impact of double-layer sign in eyes with foveal-sparing geographic atrophy and age-related macular degeneration","volume":"63","author":"Fukuyama","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"10.1016\/j.ajo.2024.07.035_bib0063","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.1167\/iovs.14-15480","article-title":"Predictive value of outer retina en face OCT imaging for geographic atrophy progression","volume":"56","author":"Giocanti-Auregan","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0064","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamaophthalmol.2019.1318","article-title":"Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration","volume":"137","author":"Grassmann","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.035_bib0065","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.12.5.2","article-title":"Monitoring lesion area progression in stargardt disease: a comparison of en face optical coherence tomography and fundus autofluorescence","volume":"12","author":"Greenstein","year":"2023","journal-title":"Transl vis sci technol"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0066","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ophtha.2014.08.035","article-title":"Outer retinal tubulation as a predictor of the enlargement amount of geographic atrophy in age-related macular degeneration","volume":"122","author":"Hariri","year":"2015","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.035_bib0067","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ophtha.2019.12.009","article-title":"Natural history of geographic atrophy secondary to age-related macular degeneration: results from the prospective Proxima A and B clinical trials","volume":"127","author":"Holekamp","year":"2020","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.035_bib0068","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of Lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.035_bib0069","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.ajo.2015.08.024","article-title":"Randomized trial to evaluate tandospirone in geographic atrophy secondary to age-related macular degeneration: the GATE study","volume":"160","author":"Jaffe","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.035_bib0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.61.4.13","article-title":"Progressive Choriocapillaris impairment in ABCA4 maculopathy is secondary to retinal pigment epithelium atrophy","volume":"61","author":"Jauregui","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0071","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/eye.2013.275","article-title":"Predictors for the progression of geographic atrophy in patients with age-related macular degeneration: fundus autofluorescence study with modified fundus camera","volume":"28","author":"Jeong","year":"2014","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0072","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.ophtha.2013.03.029","article-title":"Incidence and progression of geographic atrophy: observations from a population-based cohort","volume":"120","author":"Joachim","year":"2013","journal-title":"Ophthalmology"},{"issue":"10411","key":"10.1016\/j.ajo.2024.07.035_bib0073","first-page":"1449","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0074","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.oret.2020.03.019","article-title":"Orally administered alpha lipoic acid as a treatment for geographic atrophy: a randomized clinical trial","volume":"4","author":"Kim","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.035_bib0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ajo.2008.05.050","article-title":"The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study","volume":"146","author":"Klein","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0076","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1167\/iovs.18-25878","article-title":"Systemic levels of interleukin-6 correlate with progression rate of geographic atrophy secondary to age-related macular degeneration","volume":"60","author":"Krogh Nielsen","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0077","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/IAE.0000000000002789","article-title":"Phase 2 study of the safety and efficacy of brimonidine drug delivery system (brimo dds) generation 1 in patients with geographic atrophy secondary to age-related macular degeneration","volume":"41","author":"Kuppermann","year":"2021","journal-title":"Retina"},{"issue":"15","key":"10.1016\/j.ajo.2024.07.035_bib0078","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1167\/iovs.16-20963","article-title":"Asymmetric inter-eye progression in Stargardt disease","volume":"57","author":"Lambertus","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"10.1016\/j.ajo.2024.07.035_bib0079","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1167\/iovs.16-19833","article-title":"Progression of late-onset Stargardt disease","volume":"57","author":"Lambertus","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.035_bib0080","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1167\/iovs.13-12284","article-title":"Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration","volume":"54","author":"Lee","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2024.07.035_bib0081","doi-asserted-by":"crossref","unstructured":"Li C.H.Z., Pas J., Corradi Z., et al. Study of late-onset Stargardt type 1 disease: characteristics, genetics and progression. 2023;doi:10.1016\/j.ophtha.2023.08.011","DOI":"10.1016\/j.ophtha.2023.08.011"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0082","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0083","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1167\/iovs.16-20980","article-title":"Differential disease progression in atrophic age-related macular degeneration and late-onset Stargardt disease","volume":"58","author":"Lindner","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.035_bib0084","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s00417-021-05255-4","article-title":"Long-term progression of geographic atrophy in age-related macular degeneration does the phakic status matter?","volume":"259","author":"Madeira","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0085","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.1038\/s41598-023-34139-2","article-title":"Clinical validation for automated geographic atrophy monitoring on OCT under complement inhibitory treatment","volume":"13","author":"Mai","year":"2023","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.035_bib0086","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1167\/iovs.12-11073","article-title":"Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration","volume":"54","author":"Marsiglia","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0087","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajo.2012.01.019","article-title":"Progression of retinal pigment epithelial atrophy in Stargardt disease","volume":"154","author":"McBain","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2024.07.035_bib0088","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1167\/tvst.7.6.40","article-title":"The rate of progression of geographic atrophy decreases with increasing baseline lesion size even after the square root transformation","volume":"7","author":"Mones","year":"2018","journal-title":"Transl vis Sci Technol"},{"key":"10.1016\/j.ajo.2024.07.035_bib0089","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajo.2019.12.006","article-title":"A framework for multiscale quantitation of relationships between choriocapillaris flow impairment and geographic atrophy growth","volume":"214","author":"Moult","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.035_bib0090","first-page":"2343","article-title":"Progression of ABCA4-related retinopathy prognostic value of demographic, functional, genetic, and imaging parameters. article","volume":"40","author":"Muller","year":"2020","journal-title":"Retina-J Retinal Vitreous Dis"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0091","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212563","article-title":"Choriocapillaris flow impairment surrounding geographic atrophy correlates with disease progression","volume":"14","author":"Nassisi","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajo.2024.07.035_bib0092","series-title":"Trial Registry Record","article-title":"Metformin for the minimization of geographic atrophy progression in patients with AMD","year":"2016"},{"key":"10.1016\/j.ajo.2024.07.035_bib0093","series-title":"Trial Registry Record","article-title":"Safety and efficacy of emixustat in Stargardt disease","year":"2018"},{"key":"10.1016\/j.ajo.2024.07.035_bib0094","series-title":"Trial Registry Record","article-title":"Study to compare the efficacy and safety of intravitreal APL-2 Therapy with sham injections in patients with geographic atrophy (GA) secondary to age-related macular degeneration","year":"2018"},{"key":"10.1016\/j.ajo.2024.07.035_bib0095","series-title":"Trial Registry Record","article-title":"Study to compare the efficacy and safety of intravitreal APL-2 therapy with sham injections in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)","year":"2018"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0096","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.oret.2020.06.012","article-title":"Effect of human central nervous system stem cell subretinal transplantation on progression of geographic atrophy secondary to nonneovascular age-related macular degeneration","volume":"5","author":"Nittala","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0097","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.ophtha.2016.04.042","article-title":"Fully automated prediction of geographic atrophy growth using quantitative spectral-domain optical coherence tomography biomarkers","volume":"123","author":"Niu","year":"2016","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.035_bib0098","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3928\/23258160-20130715-06","article-title":"Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina","volume":"44","author":"Nunes","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"17","key":"10.1016\/j.ajo.2024.07.035_bib0099","first-page":"3705","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial","volume":"37","author":"Patel","year":"2023"},{"issue":"5","key":"10.1016\/j.ajo.2024.07.035_bib0100","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/bjophthalmol-2012-302633","article-title":"Fundus autofluorescence and microperimetry in progressing geographic atrophy secondary to age-related macular degeneration","volume":"97","author":"Pilotto","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0101","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/IAE.0000000000002653","article-title":"Investigating a growth prediction model in advanced age-related macular degeneration with solitary geographic atrophy using quantitative autofluorescence","volume":"40","author":"Reiter","year":"2020","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0102","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.oret.2018.03.001","article-title":"A randomized phase 2 study of an anti-amyloid beta monoclonal antibody in geographic atrophy secondary to age-related macular degeneration","volume":"2","author":"Rosenfeld","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0103","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.ophtha.2018.03.059","article-title":"Emixustat hydrochloride for geographic atrophy secondary to age-related macular degeneration: a randomized clinical trial","volume":"125","author":"Rosenfeld","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0104","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/IAE.0000000000003305","article-title":"Choroidal vascularity index is associated with geographic atrophy progression","volume":"42","author":"Sacconi","year":"2022","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bjophthalmol-2019-315800","article-title":"Choriocapillaris flow impairment could predict the enlargement of geographic atrophy lesion","volume":"105","author":"Sacconi","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.07.035_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.102171","article-title":"Impact of ocular and systemic risk factors on progression of geographic atrophy in age-related macular degeneration","volume":"33","author":"Sahinoglu-Keskek","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0107","first-page":"901","article-title":"Clinical characteristics and progression of geographic atrophy in a Japanese population","volume":"7","author":"Sato","year":"2023"},{"key":"10.1016\/j.ajo.2024.07.035_bib0108","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajo.2017.03.031","article-title":"Geographic atrophy and foveal-sparing changes related to visual acuity in patients with dry age-related macular degeneration over time","volume":"179","author":"Sayegh","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0109","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1167\/iovs.11-7457","article-title":"Semiautomated image processing method for identification and quantification of geographic atrophy in age-related macular degeneration","volume":"52","author":"Schmitz-Valckenberg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ophtha.2015.09.036","article-title":"Natural history of geographic atrophy progression secondary to age-related macular degeneration (Geographic Atrophy Progression Study)","volume":"123","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2024.07.035_bib0111","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajo.2020.12.015","article-title":"Correlations between choriocapillaris and choroidal measurements and the growth of geographic atrophy using swept source OCT imaging","volume":"224","author":"Shi","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.07.035_bib0112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.11.1.19","article-title":"Progression of cRORA (complete RPE and outer retinal atrophy) in dry age-related macular degeneration measured using SD-OCT","volume":"11","author":"Shmueli","year":"2022","journal-title":"Transl vis sci technol"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.035_bib0113","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ajo.2014.05.026","article-title":"A longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy","volume":"158","author":"Simader","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0114","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1167\/iovs.13-13199","article-title":"OCT minimum intensity as a predictor of geographic atrophy enlargement","volume":"55","author":"Stetson","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bjophthalmol-2020-316004","article-title":"Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression","volume":"105","author":"Thiele","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2024.07.035_bib0116","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.oret.2018.09.004","article-title":"En face imaging of geographic atrophy using different swept-source OCT scan patterns","volume":"3","author":"Thulliez","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2024.07.035_bib0117","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1167\/iovs.10-5637","article-title":"Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial","volume":"51","author":"Wong","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0118","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/IAE.0b013e31828991b2","article-title":"Reticular macular disease is associated with multilobular geographic atrophy in age-related macular degeneration","volume":"33","author":"Xu","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2024.07.035_bib0119","doi-asserted-by":"crossref","unstructured":"Yaspan B.L., Williams D.F., Holz F.G., et al. Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration. 2017;doi:10.1126\/scitranslmed.aaf1443","DOI":"10.1126\/scitranslmed.aaf1443"},{"issue":"3","key":"10.1016\/j.ajo.2024.07.035_bib0120","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"issue":"15","key":"10.1016\/j.ajo.2024.07.035_bib0121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.62.15.28","article-title":"Geographic atrophy progression is associated with choriocapillaris flow deficits measured with optical coherence tomographic angiography","volume":"62","author":"You","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"10.1016\/j.ajo.2024.07.035_bib0122","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1073\/pnas.1018987108","article-title":"Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.035_bib0123","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1167\/iovs.16-19388","article-title":"Frequency, phenotypic characteristics and progression of atrophy associated with a diseased bruch's membrane in pseudoxanthoma elasticum","volume":"57","author":"Gliem","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.035_bib0124","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajo.2013.05.034","article-title":"Geographic chorioretinal atrophy in pseudoxanthoma elasticum","volume":"156","author":"Schoenberger","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0125","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ophtha.2019.05.015","article-title":"Natural history of autosomal recessive stargardt disease in untreated eyes: a systematic review and meta-analysis of study- and individual-level data","volume":"126","author":"Shen","year":"2019","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0126","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1167\/iovs.11-7235","article-title":"Reticular drusen associated with geographic atrophy in age-related macular degeneration","volume":"52","author":"Schmitz-Valckenberg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2024.07.035_bib0127","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ophtha.2016.12.002","article-title":"Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from classification of atrophy consensus meetings","volume":"124","author":"Holz","year":"2017","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0128","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1097\/IAE.0b013e3182509778","article-title":"Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area","volume":"32","author":"Khanifar","year":"2012","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ajo.2024.07.035_bib0129","doi-asserted-by":"crossref","first-page":"e617","DOI":"10.1016\/S2589-7500(21)00204-1","article-title":"Deep learning in geographic atrophy: the best is yet to come","volume":"3","author":"Biarnes","year":"2021","journal-title":"Lancet Digit Health"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.oret.2022.03.017","article-title":"Correlation between fundus autofluorescence and en face OCT measurements of geographic atrophy","volume":"6","author":"Velaga","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.ajo.2024.07.035_bib0131","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/aos.15796","article-title":"Multimodal imaging and deep learning in geographic atrophy secondary to age-related macular degeneration","volume":"101","author":"Pfau","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2024.07.035_bib0132","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3928\/23258160-20160707-07","article-title":"Progression of macular atrophy in pattern dystrophies","volume":"47","author":"Pallado","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"9","key":"10.1016\/j.ajo.2024.07.035_bib0133","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bjo.2004.062695","article-title":"Genetic and phenotypic heterogeneity in pattern dystrophy","volume":"89","author":"Francis","year":"2005","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424003520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T17:20:13Z","timestamp":1738603213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424003520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":133,"alternative-id":["S0002939424003520"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.07.035","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression Rate of Macular Retinal Pigment Epithelium Atrophy in Geographic Atrophy and Selected Inherited Retinal Dystrophies. A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}